Modulation of quantal dopamine release by psychostimulants.
Pothos
E N
EN
Department of Neurology, Columbia University, New York, New York 10032, USA.
Sulzer
D
D
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D002478:Cells, Cultured; D003042:Cocaine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D007980:Levodopa / Q000494:pharmacology; D009268:Nalidixic Acid / Q000031:analogs & derivatives; D009287:Naphthyridines / Q000494:pharmacology; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D016716:PC12 Cells; D011188:Potassium / Q000494:pharmacology; D011789:Quantum Theory; D051381:Rats; D013111:Spider Venoms / Q000494:pharmacology; D013681:Tegmentum Mesencephali / Q000502:physiology*
D018765:Dopamine Uptake Inhibitors; D009287:Naphthyridines; D013111:Spider Venoms; D009268:Nalidixic Acid; D007980:Levodopa; C020763:alpha-latrotoxin; D003042:Cocaine; C006486:amfonelic acid; D011188:Potassium; D004298:Dopamine